Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Fresenius Medical Care, a major provider of renal disease products, will start the new year with a new global chief medical ...

Kidney disease doesn’t arrive with sirens. It doesn’t announce itself loudly. Most of the time, it slips in quietly, doing ...

Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

On December 17, Lale Akoner, Global Market Analyst at eToro, appeared on CNBC to suggest that she is observing capital moving ...

A new study published in the journal of Nature Scientific Reports showed that patients with end-stage renal disease (ESRD) ...

Culturally congruent care and better understanding of the underlying causes are crucial to help achieve equitable treatment ...

Many people take for granted the ability to travel and spend time with family and friends at their leisure — and the ability ...

Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), today announced an exclusive licensing agreement for the development and commercialisation of givinostat in Japan. Under the ...

As the New Year begins with renewed focus on health and well-being, Qris Health, a digital healthcare and diagnostics ...

Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal ...